204 related articles for article (PubMed ID: 37378889)
1. Functions, mechanisms, and clinical applications of lncRNA LINC00857 in cancer pathogenesis.
Aldayyeni H; Hjazi A; Shahab S; Gupta J; Alsaab HO; Motea YH; Alazbjee AAA; Romero-Parra RM; Obaid RF; Hussien BM; Hosseini-Fard SR
Hum Cell; 2023 Sep; 36(5):1656-1671. PubMed ID: 37378889
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA LINC00857 Promotes Proliferation, Migration, and Invasion of Colorectal Cancer Cell through miR-1306/Vimentin Axis.
Chang N; Cui Y; Liang X; Han D; Zheng X; Wu A; Qian L
Comput Math Methods Med; 2021; 2021():5525763. PubMed ID: 33833823
[TBL] [Abstract][Full Text] [Related]
3. LncRNA LINC00857 regulates the progression and glycolysis in ovarian cancer by modulating the Hippo signaling pathway.
Lin X; Feng D; Li P; Lv Y
Cancer Med; 2020 Nov; 9(21):8122-8132. PubMed ID: 32918541
[TBL] [Abstract][Full Text] [Related]
4. LINC00857 regulated by ZNF460 enhances the expression of CLDN12 by sponging miR-150-5p and recruiting SRSF1 for alternative splicing to promote epithelial-mesenchymal transformation of pancreatic adenocarcinoma cells.
Zhang Y; Fang Y; Ma L; Xu J; Lv C; Deng L; Zhu G
RNA Biol; 2022; 19(1):548-559. PubMed ID: 35442145
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
6. Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer.
Wang L; He Y; Liu W; Bai S; Xiao L; Zhang J; Dhanasekaran SM; Wang Z; Kalyana-Sundaram S; Balbin OA; Shukla S; Lu Y; Lin J; Reddy RM; Carrott PW; Lynch WR; Chang AC; Chinnaiyan AM; Beer DG; Zhang J; Chen G
Oncotarget; 2016 Mar; 7(10):11487-99. PubMed ID: 26862852
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
[TBL] [Abstract][Full Text] [Related]
8. Long non‑coding RNA ENST00000547547 inhibits cell proliferation, invasion and migration in colorectal cancer cells.
Ai X; Lei Q; Shen X; Li J; Cen C; Xie G; Luo B; Zhu W; Hu G; Wu H; Chen M; Li X; Lin C
Oncol Rep; 2019 Jan; 41(1):483-491. PubMed ID: 30542703
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
10.
Terashima M; Ishimura A; Wanna-Udom S; Suzuki T
J Biol Chem; 2018 Nov; 293(47):18016-18030. PubMed ID: 30262664
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
Wu D; He X; Wang W; Hu X; Wang K; Wang M
Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1.
Wu Q; Xiang S; Ma J; Hui P; Wang T; Meng W; Shi M; Wang Y
Mol Oncol; 2018 Jun; 12(6):799-813. PubMed ID: 29489064
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
14. LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.
Li T; Zhao H; Zhou H; Geng T
PLoS One; 2021; 16(3):e0247817. PubMed ID: 33661995
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter.
Gao LM; Xu SF; Zheng Y; Wang P; Zhang L; Shi SS; Wu T; Li Y; Zhao J; Tian Q; Yin XB; Zheng L
J Cell Mol Med; 2019 Sep; 23(9):6411-6428. PubMed ID: 31317666
[TBL] [Abstract][Full Text] [Related]
16. SP1-activated long noncoding RNA lncRNA GCMA functions as a competing endogenous RNA to promote tumor metastasis by sponging miR-124 and miR-34a in gastric cancer.
Tian Y; Ma R; Sun Y; Liu H; Zhang H; Sun Y; Liu L; Li Y; Song L; Gao P
Oncogene; 2020 Jun; 39(25):4854-4868. PubMed ID: 32439864
[TBL] [Abstract][Full Text] [Related]
17. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
Tuo Z; Zhang J; Xue W
Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
[TBL] [Abstract][Full Text] [Related]
18. LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway.
Peng W; He D; Shan B; Wang J; Shi W; Zhao W; Peng Z; Luo Q; Duan M; Li B; Cheng Y; Dong Y; Tang F; Zhang C; Duan C
Cell Death Dis; 2019 Jul; 10(7):533. PubMed ID: 31296840
[TBL] [Abstract][Full Text] [Related]
19. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes.
Wang X; Li X; Wang Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649837
[TBL] [Abstract][Full Text] [Related]
20. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
